19 June 2013
Keywords: new, clinical, data, back, up, raptiva, efficacy
Article | 31 March 2003
Raptiva (efalizumab), developed by Xoma and Genentech in the USA andlicensed to Serono in Europe, has shown efficacy in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 March 2003
21 April 2003
18 June 2013
© 2013 thepharmaletter.com